KOEI CHEMICAL COMPANY LIMITED

KOEI CHEMICAL COMPANY LIMITED

TTSE:4367
2,550.00
JPY
-47.00
(-1.81%)
11.22BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
3,425.33
3,814.57
3,736.02
3,531.69
3,709.06
3,743.01
3,788.04
3,596.15
3,536.23
3,803.2
3,971.93
4,092.79
3,477.64
- -
Basic EPS, GAAP
15.2
67.28
88.92
232.03
1,112.47
196.45
320.6
378.51
192.32
141.24
61.26
58.96
-1,049.89
- -
Free Cash Flow per Basic Share
288.21
234.47
152.42
-551.1
-330.68
-359.62
-392.63
-609.1
-446.63
-1,106.04
382.8
637.36
111.19
- -
Dividend per Share
- -
15
35
40
90
60
60
90
110
100
100
100
80
- -
Book Value per Share
2,557.96
2,675.7
2,734.64
2,961.47
3,978.48
4,115.69
4,292.82
4,511.57
4,484.59
4,509.14
4,461.11
4,419.56
3,289.66
4,461.08
Tangible Book Value per Share
2,551.87
2,671.03
2,721.84
2,951.42
3,969.86
4,097.25
4,259.33
4,481.4
4,459.13
4,488.62
4,441.23
4,397.9
3,268.82
4,443.22
Basic Weighted Avg Shares
5
5
5
5
5
5
5
5
5
5
5
5
5
5
Sales/Revenue/Turnover
16,742
18,665
18,279
17,279
18,144
18,309
18,529
17,590
17,296
18,602
19,427
20,018
17,009
- -
Operating Margin (%)
1.24
4.55
7.78
8.12
8.42
6.39
10.01
8.44
2.94
4.47
2.14
2.83
2.14
- -
Depreciation Expense
1,558
1,468
1,203
1,147
1,276
1,279
1,433
1,601
1,820
2,439
2,966
3,026
2,797
- -
Net Income, GAAP
74
329
435
1,135
5,442
961
1,568
1,851
941
691
300
288
-5,135
- -
Effective Tax Rate (%)
46.98
44.66
34.36
26.57
30.17
24.42
25.33
24.52
24.36
25.38
16.44
13.65
- -
- -
Profit Margin (%)
0.44
1.76
2.38
6.57
29.99
5.25
8.46
10.53
5.44
3.71
1.54
1.44
-30.19
- -
Working Capital
4,050
5,834
5,676
4,238
8,119
7,460
7,691
7,501
6,848
6,251
5,443
5,774
5,571
5,932
LT Debt
48
36
24
18
8
2
1
2,000
4,408
6,012
5,811
4,130
2,834
4,001
Total Equity
12,552
13,092
13,380
14,488
19,461
20,132
20,997
22,067
21,935
22,055
21,820
21,616
16,090
21,820
Return on Invested Capital (%)
0.02
2.36
5.36
6.52
5.54
4.12
6.35
4.7
1.46
2.07
1.07
1.59
- -
- -
Return on Capital (%)
0.54
2.25
3.02
7.39
29.71
4.68
7.34
7.96
3.68
2.4
1.06
1.19
- -
- -
Return on Common Equity (%)
0.6
2.57
3.29
8.15
32.06
4.85
7.63
8.6
4.28
3.14
1.37
1.33
-27.24
- -

Capital Structure

JPY

•

in mil. unless spec.
Dec'24
Mar'24
Sep'25
ST Debt
4,116
4,490
3,316
LT Borrowings
5,584
4,834
4,001
LT Finance Leases
- -
977
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
11,034
11,210
11,215

Working Capital

JPY

•

in mil. unless spec.
Dec'24
Mar'24
Sep'25
Total Current Assets
16,266
14,936
14,858
Cash, Cash Equivalents & STI
634
563
661
Accounts Receivable, Net
4,399
5,574
4,192
Inventories
10,853
8,381
9,271
Total Current Liabilities
10,106
9,493
8,926
Payables & Accruals
- -
- -
- -
ST Debt
4,116
4,490
3,316
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.78%
-5.52%
-25.57%
Free Cash Flow
-45.82%
-5.94%
-82.55%
Net Income, GAAP
-147.76%
-403.35%
-1,880.64%
Sales/Revenue/Turnover
-0.51%
-0.33%
-15.03%
Total Cash Common Dividend
- -
- -
-20%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,670
4,656
4,734
6,367
19,427
2025
- -
- -
- -
- -
20,018
2026
- -
- -
- -
- -
17,009

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
33.52
1.98
-1.53
27.28
61.26
2025
- -
- -
- -
- -
58.96
2026
- -
- -
- -
- -
-1,049.89

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
100
2025
- -
- -
- -
- -
100
2026
- -
- -
- -
- -
80

Company Description

CEO
Yasuaki Sasaki
Full Time Employees
402
Sector
Process industries
Industry
Chemicals: major diversified
Address
1-8, Nihonbashi-Koamicho Tokyo TY Japan 103-0016
IPO Date
Oct 2, 1997
Business
Koei Chemical Company, Limited, founded in 1925 and headquartered in Chiba, Japan, operates as a specialized chemical manufacturer primarily focused on nitrogen-containing compounds. The company produces and distributes a broad portfolio of chemical products including ionic liquids; amines such as 1,2-diaminopropane and N-methylpiperazines; pyridine bases including pyridines, a-picoline, and 4-ethylpyridine; pyrazines; polyols used in alkyd resin paints for architectural and automotive applications; formalin products; and methanol. These chemical products are utilized in diverse industrial applications ranging from fine organic synthesis, pharmaceutical intermediates, crop protection products, optical materials to adhesives, synthetic resins, paints, lubricant additives, and ultraviolet inks. Koei Chemical’s operations extend geographically across Japan, Asia, Europe, and North America. The company operates through two main segments: Fine Products, which includes high-value chemical intermediates primarily for pharmaceuticals and agrochemicals, and Basic Products encompassing a wide range of amines, pyridines, and polyols. It leverages advanced manufacturing facilities for fine organic synthesis, high-pressure hydrogenation, and gas-phase reactions, supporting efficient and large-scale production. Recent strategic developments include a strengthened collaboration with Sumitomo Chemical Group aimed at accelerating new product development, particularly in custom synthesis and specialty chemicals. The company has expanded its business portfolio by launching new products, such as low-temperature curing catalysts for polyurethane, and has increased capacity with the construction and commencement of operations at the CM IV plant in Chiba. Koei Chemical is enhancing its competitiveness through structural capital investments, consolidation of production sites, and a focus on sustainability initiatives including carbon neutrality. It is also actively exploring new business fields like optical/electronic materials and battery materials to diversify beyond traditional chemical markets. Through these initiatives, Koei Chemical aims to extend its product applications, improve production efficiency, and expand its global market presence, while maintaining a strong focus on innovation in nitrogen-based chemical compounds. The company’s recent moves represent a strategic expansion in fine chemicals and custom synthesis fields, positioning it for sustained growth in specialty chemicals and advanced materials.